| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $4,915,568 ) |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL161238 | Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | 000 | 4 | NIH | 1/8/2025 | $896,400 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI155749 | MDS-Associated Spliceosome Mutations Regulate Host Defense | 000 | 5 | NIH | 2/28/2025 | $523,165 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 000 | 13 | NIH | 3/3/2025 | $643,294 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AI152037 | ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER | 000 | 6 | NIH | 3/31/2025 | $329,638 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI151021 | Transcriptional Control of T Cell Function | 000 | 5 | NIH | 3/17/2025 | $397,700 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL173239 | Integrative Metabolomics of Sarcoidosis Diagnosis and Progression | 000 | 1 | NIH | 4/1/2025 | $760,374 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL157424 | Proteolysis in the Pathogenesis of ARDS | 000 | 4 | NIH | 11/12/2024 | $614,895 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL155894 | Interstitial macrophages in cigarette smoke-induced small airway remodeling | 000 | 4 | NIH | 12/23/2024 | $158,328 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01ES033678 | Using Multi-Omics to Define Regulators and Drivers of Granulomatous Inflammation and Chronic Beryllium Disease | 000 | 4 | NIH | 11/27/2024 | $636,949 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08ES034820 | Transcriptional Responses to Wildfire Pollution in Airway Epithelial Cells Identify Genetic Risk Factors and Mechanisms of Asthma Exacerbations | 000 | 3 | NIH | 12/16/2024 | $174,528 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI182277 | Mast Cell Lineage Commitment and Function | 000 | 1 | NIH | 12/2/2024 | $612,328 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K01DK134835 | Transcriptional control of T cell function during type 1 diabetes | 000 | 2 | NIH | 12/11/2024 | $114,626 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H3700066 | BLACK LUNG | 02 | 22 | HRSA | 12/11/2024 | $0 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | UM1AI151958 | ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER | 000 | 5 | NIH | 2/12/2025 | $0 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H1G53351 | Radiation Exposure Screening and Education Program | 02 | 1 | HRSA | 1/22/2025 | $0 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL144727 | Mechanisms of Right Ventricle Adaptation to Pulmonary Hypertension | 000 | 5 | NIH | 12/11/2024 | $0 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R00HL161320 | RNA editing controls pulmonary endothelial pathophenotypes in pulmonary hypertension | 000 | 3 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL171850 | Bcl-2 dependent fibroblast resistance to apoptosis occurs through persistent IL-6 signaling | 000 | 1 | NIH | 10/16/2024 | $0 |
| | 2025 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H1G53351 | Radiation Exposure Screening and Education Program | 01 | 1 | HRSA | 11/29/2024 | $0 |
| | 2025 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K23HL163313 | MicroRNA as Diagnostic and Prognostic Biomarkers in Sarcoidosis | 000 | 1 | NIH | 2/25/2025 | -$143,987 |
| | 2025 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL166828 | Decay accelerating factor (CD55) protects against lectin pathway-mediated AT2 cell dysfunction in cigarette smoke-induced emphysema | 001 | 1 | NIH | 2/25/2025 | -$760,358 |
| | 2025 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL148335 | Temporal regulation of pulmonary inflammation by MyD88 alternative pre-mRNA splicing | 000 | 4 | NIH | 10/28/2024 | -$1 |
| | 2025 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R56HL157318 | Mechanism of Prostone Activation During CFTR Modulation | 000 | 1 | NIH | 3/24/2025 | -$8,622 |
| | 2025 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R21ES032973 | Environmental Factors Predicting Risk of Severe COVID Infection | 000 | 2 | NIH | 2/25/2025 | -$5,292 |
| | 2025 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL144727 | Mechanisms of Right Ventricle Adaptation to Pulmonary Hypertension | 001 | 4 | NIH | 2/17/2025 | $0 |
| | 2025 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | UG1HL139123 | Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE) | 000 | 6 | NIH | 12/5/2024 | -$15,153 |
| | 2025 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R21ES032951 | Repurposing thiosulfate for chlorine gas exposure | 000 | 2 | NIH | 12/19/2024 | $0 |
| | 2025 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI141389 | Neutrophil Nox2 controls mononuclear cell functions in inflammation; role in CGD | 000 | 5 | NIH | 11/22/2024 | $0 |
| | 2025 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI135194 | Regulation of Gene Expression in the anaphylactic Pathway | 000 | 5 | NIH | 11/22/2024 | $0 |
| | 2025 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI137970 | Steroid resistance of airway ILC2s | 000 | 5 | NIH | 11/22/2024 | $0 |
| | 2025 | 2021 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL137995 | Biomarker of Lung Disease in African Americans | 001 | 4 | NIH | 10/17/2024 | -$27 |
| | 2025 | 2021 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL137995 | Biomarker of Lung Disease in African Americans | 000 | 4 | NIH | 10/17/2024 | -$116 |
| | 2025 | 2021 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | P01HL132821 | Defining Molecular Phenotypes of Exacerbation Prone Asthmatics | 000 | 5 | NIH | 2/7/2025 | -$5,635 |
| | 2025 | 2021 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL135156 | Transcriptomic and Pharmacogenetic Asthma Endotypes in Minority Children | 000 | 5 | NIH | 11/7/2024 | -$7,465 |
|
| Issue Date FY: 2024 ( Subtotal = $25,792,870 ) (Continued on the next page) |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL140039 | Lung Macrophage Programming in Acute Lung Injury | 002 | 7 | NIH | 6/19/2024 | $76,043 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL140039 | Lung Macrophage Programming in Acute Lung Injury | 001 | 7 | NIH | 1/29/2024 | $855,492 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R21ES036375 | The Role of Airway Epithelial Complement in Chronic Beryllium Disease | 000 | 1 | NIH | 9/18/2024 | $470,500 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01DA057266 | Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy | 001 | 2 | NIH | 7/3/2024 | $538,289 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL171850 | Bcl-2 dependent fibroblast resistance to apoptosis occurs through persistent IL-6 signaling | 000 | 1 | NIH | 7/9/2024 | $156,816 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL168278 | Reparative functions of human airspace macrophage subsets | 000 | 1 | NIH | 7/12/2024 | $602,955 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI155749 | MDS-Associated Spliceosome Mutations Regulate Host Defense | 001 | 4 | NIH | 5/31/2024 | $53,935 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI155749 | MDS-Associated Spliceosome Mutations Regulate Host Defense | 000 | 4 | NIH | 2/20/2024 | $485,411 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL141264 | Role of FABP5 in COPD Exacerbations | 002 | 5 | NIH | 7/29/2024 | $597,510 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H3700066 | BLACK LUNG | 00 | 22 | HRSA | 5/30/2024 | $784,031 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H3700066 | BLACK LUNG | 01 | 22 | HRSA | 8/20/2024 | $0 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL077328 | Ceramide-Induced Destruction in Emphysema | 000 | 19 | NIH | 6/6/2024 | $676,133 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 001 | 12 | NIH | 6/21/2024 | $58,121 |
| | 2024 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 000 | 12 | NIH | 2/27/2024 | $653,847 |
|
